CanaFarma Hemp (CNFA) is getting the first month of trading under its belt. If you were to pick a month to go public I’m not sure this would be it. Regardless, CanaFarma is successfully trading in two markets, soon to be three.
CanaFarma launched trading in Canada in March and on the German Borse a week later. Cannabis and Hemp stocks have traded solidly since the COVID-19 outbreak proving the sector is really a safe port. The consumer is sitting home assessing the shock of the virus during the shutdown.
It has been interesting to chronicle the launch of CanaFarma and watch the company datapoint moves across the landscape. The true advantage is to watch the first few trades on multiple exchanges. We think any management team that survives is better for it.
Many think this is possible because the company has a revenue stream in it’s Yooforic CBD Gum product. This roll-up was long in the making, and the company walked through a minefield during February and stayed the course.
We spoke to the company in January click below to listen to the podcast with Vitaly Fargesen who was looking for a valuation near $100 million based on the sales of Yoofiric Gum, and the team’s experience.
The companies value today is (based on last sale) is $130 Million so they were not far off in their expectations. They seemed to understand prior to launch how the market is assigning multiples to the industry. But we venture no one would have predicted Cannabis Sector Stock would hold multiples during the Covid-19 environment for public companies.
Click below to listen to Vitaly Fargesen Podcast
MARKET NEWS FIRST (MN1.COM) INTERVIEW WITH VITALY FARGESEN OF CANAFARMA CORP is a wide-ranging Q&A with Vitaly Fargesen with MN1 host Josh Lankford explaining company strategy for 2020. Click here to listen to the interview.
Click below to listen to Frank Barone podcast on Sales and Marketing
MASTER OF DIRECT TO CONSUMER (D2C) SALES is an interview with Frank Barone who provides leadership in the affiliate marketing program and strategy at the company. It is an informative view from inside the company spoken clearly by Mr. Barone. Click here to listen to the interview.
The companies value today is (based on the last sale) is $130 Million so they were not far off in their expectations. They seemed to understand prior to launch how the market was assigning multiples to the industry. But we venture no one would have predicted Cannabis Sector Stock would hold multiples during the COVID-19 environment for public companies.
